About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Clinical Pharmacokinetics
›
Top Articles
Clinical Pharmacokinetics
Pharmacology
6.2
(top 2%)
Impact Factor
6.7
(top 2%)
extended IF
184
(top 1%)
H-Index
1.3K
authors
3.3K
papers
184.9K
citations
7K
citing journals
61.7K
citing authors
Most Cited Articles of Clinical Pharmacokinetics
Title
Year
Citations
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies
2003
1.1K
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models
1981
837
Pharmacokinetics and pharmacodynamics of cannabinoids
2003
795
Clinical pharmacology of tramadol
2004
752
Clinical pharmacokinetics of metformin
2011
690
Pegylation: a novel process for modifying pharmacokinetics
2001
650
Clinical significance of the cytochrome P450 2C19 genetic polymorphism
2002
645
Clinical pharmacokinetics of mycophenolate mofetil
1998
638
Clinical pharmacology of 5-fluorouracil
1989
624
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition
2000
623
Role of P-glycoprotein in pharmacokinetics: clinical implications
2003
593
Inhibition and induction of cytochrome P450 and the clinical implications
1998
585
Quantification of lean bodyweight
2005
577
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
2004
562
Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study
2010
554
Clinical pharmacokinetics of tacrolimus
1995
553
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
2004
549
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
1997
543
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
2005
510
Effect of obesity on the pharmacokinetics of drugs in humans
2010
482
Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach
2005
480
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
2009
474
Pharmacokinetic interactions with rifampicin : clinical relevance
2003
473
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
2008
470
Drug interactions with tobacco smoking. An update
1999
465
previous
2003
2004
2005
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.